Free Trial
OTCMKTS:WXXWY

WuXi Biologics (Cayman) (WXXWY) Stock Price, News & Analysis

$4.23
+0.01 (+0.24%)
(As of 10/23/2024 ET)

About WuXi Biologics (Cayman) Stock (OTCMKTS:WXXWY)

Key Stats

Today's Range
$4.21
$4.28
50-Day Range
$2.59
$5.85
52-Week Range
$2.58
$13.25
Volume
17,909 shs
Average Volume
175,693 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and engages in investment and material supplier activities. The company has a research service agreement with BioNTech SE to discover and investigate monoclonal antibodies for developing next-generation therapeutic product candidates. The company was incorporated in 2014 and is headquartered in Wuxi, China.

Receive WXXWY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for WuXi Biologics (Cayman) and its competitors with MarketBeat's FREE daily newsletter.

WXXWY Stock News Headlines

DBS Keeps Their Hold Rating on Wuxi Biologics (Cayman) (WXIBF)
Watch this before it gets removed
If you missed it, my emergency election broadcast is now available - but will be removed soon
DBS Remains a Hold on Wuxi Biologics (Cayman) (WXIBF)
Wuxi Biologics (Cayman) (WXIBF) Gets a Buy from DBS
WuXi Biologics Included in Hang Seng ESG 50 Index
See More Headlines

WXXWY Stock Analysis - Frequently Asked Questions

WuXi Biologics (Cayman)'s stock was trading at $7.45 at the beginning of 2024. Since then, WXXWY stock has decreased by 43.2% and is now trading at $4.23.
View the best growth stocks for 2024 here
.

Shares of WXXWY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:WXXWY
CIK
N/A
Fax
N/A
Employees
12,435
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

This page (OTCMKTS:WXXWY) was last updated on 10/24/2024 by MarketBeat.com Staff
From Our Partners